Atlas Trials

Ann Arbor Stage II Marginal Zone Lymphoma

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Ann Arbor Stage II Marginal Zone Lymphoma

RecordFirmDate
Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma (NCT04323956)Mayo Clinic2020-06-15
Ibrutinib in Combination With Rituximab and Lenalidomide in Treating Patients With Previously Untreated, Stage II-IV Follicular Lymphoma or Marginal Zone Lymphoma (NCT02532257)M.D. Anderson Cancer Center2016-04-11

Track Ann Arbor Stage II Marginal Zone Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.